mascmedical.com

Kelliemeredith25 Oct, 2023Business

Historically, clinical trials predominantly featured North American-based epigenetic profiling. However, with the recognition that certain races or ethnicities are predisposed to specific conditions, a shift towards more inclusive, genetics-based trials is evident. Such trials can offer hope to those grappling with traditionally fatal diseases, paving the way for personalized therapies.